Esophageal Diseases  >>  dexlansoprazole  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dexlansoprazole / Generic mfg.
NCT01328392: Evaluating Treatment Response in Laryngo-Pharyngeal Reflux

Withdrawn
N/A
0
US
Dexlansoprazole, Dexilant
University of Washington, Takeda Pharmaceuticals North America, Inc.
Laryngo-pharyngeal Reflux
04/12
04/12
NCT00880906: Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis

Completed
N/A
50
US
Esophageal dilation, esophageal stretching, Steroid and Proton Pump Inhibitor Therapy, fluticasone, dexilant
Vanderbilt University, Takeda
Suspected Eosinophilic Esophagitis
12/13
12/13

Download Options